Search Results 791-800 of 1774 for 구글찌라시 を 18242033 を텔@adtopkingをを구글자동등록ををを텔@adtopkingををを검색상위ををを
Necuparanib has been re-engineered from heparin to have much lower blood thinning activity while keeping the anti-tumor activity. The investigators are testing ...
Dr. LaRusso holds several U.S. patents for his work in the Cholangiopathies Lab and collaborates with other investigators on liver diseases.
The purpose of this study is to develop and validate a brief patient reported outcomes questionaire that is responsive to ascites-related symptoms in liver ...
The purpose of this study is to evaluate the most applicable endpoints for evaluation of the Biomerica InFoods® IBS product. Participation eligibility.
The atezolizumab plus obinutuzumab) (Arm E) will enroll participants with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
About this study. The purpose of this study is to determine the efficacy and safety of investigational medical products (MEDI4736 monotherapy, tremelimumab ...
About this study. Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer ...
About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...
Melissa Neuman dreaded getting mammograms. Her small, dense breasts made the screening exceptionally uncomfortable and painful. So Melissa put off getting an ...
View a list of faculty and staff in the Aspirin-Exacerbated Respiratory Disease Laboratory of Elina Jerschow, M.D., M.S., at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.